Peer Exchange

Experts discuss gut microbiota, current and emerging microbiome-based therapies for C difficile, and the practical ways to incorporate these treatments into your clinical practice.

Experts share thoughts on the flu season, the importance of testing early to differentiate between COVID-19 and influenza, and the role of clinicians and pharmacists in early testing and patient education.

A panel of infectious disease experts examines the risks and implications of multi-drug resistant HIV and discusses emerging treatment strategies that could shape clinical approaches in the future.

Expert health professionals provide key insights on recently approved SARS-CoV-2 booster shots highlighting current recommendations and optimizing patient communication and education on vaccination options.

Dr. Feuerstadt, a gastroenterologist, discusses foundational trials and ongoing studies in the use of fecal microbial transplantation (FMT) for treatment of recurrent C. difficile infections.

A panel of experts provides a thorough discussion on COVID-19 booster shots, including eligibility and safety considerations.

Expert panelists provide insight on the relationship between the gut microbiome and c difficile, leading to the development of novel therapeutic approaches for infection.

Importance of patient education and early testing to differentiate between influenza and COVID-19.

An expert multidisciplinary panel reacts to the availability of newer therapies and various strategies that may minimize adverse effects, including weight gain, from HIV treatment.

PX

PX

PX